The peripheral nervous system may be subjected to multiple simultaneous insults. These include trauma, inflammation, the effects of diseases such as diabetes and drugs, or toxins. Interactions are difficult to study in vivo. In this proposal, we will use modified isobolographic analysis to study the interaction between hypoxia- and suramin-induced neurotoxicity. One of the proposed mechanisms underlying diabetic neuropathy is vascular pathology resulting in neural hypoxia or ischemia. Suramin is an experimental chemotherapeutic agent used in the treatment of solid tumors including breast and prostate cancers. One of the dose-limiting side effects of this agent is peripheral neuropathy. The mechanisms of hypoxia- and antineoplastic agent-induced nerve injury in the peripheral nervous system (PNS) have not been fully defined and the effect of double insults has been difficult to study. We propose that suramin and hypoxia both produce nerve injury by way of calcium-mediated pathways. Using primary dorsal root ganglion neurons as an in vitro model system, we will study the mechanism of interaction and determine whether it is synergistic or additive. If there is interaction we will test the hypothesis that convergence occurs at the level of calcium signaling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32NS010282-02
Application #
2635644
Study Section
Special Emphasis Panel (ZRG1-NLS-3 (01))
Program Officer
Nichols, Paul L
Project Start
1998-01-01
Project End
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Oplustilova, Lenka; Wolanin, Kamila; Mistrik, Martin et al. (2012) Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment. Cell Cycle 11:3837-50